224 related articles for article (PubMed ID: 23661511)
1. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction.
Matsumoto S; Nakatani D; Sakata Y; Suna S; Shimizu M; Usami M; Hara M; Sumitsuji S; Nanto S; Sasaki T; Hamasaki T; Sato H; Hori M; Komuro I;
Circ J; 2013; 77(4):1026-32. PubMed ID: 23291993
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.
Hartford M; Wiklund O; Mattsson Hultén L; Persson A; Karlsson T; Herlitz J; Caidahl K
J Intern Med; 2007 Nov; 262(5):526-36. PubMed ID: 17908161
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
[TBL] [Abstract][Full Text] [Related]
5. Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes.
Mallat Z; Steg PG; Benessiano J; Tanguy ML; Fox KA; Collet JP; Dabbous OH; Henry P; Carruthers KF; Dauphin A; Arguelles CS; Masliah J; Hugel B; Montalescot G; Freyssinet JM; Asselain B; Tedgui A
J Am Coll Cardiol; 2005 Oct; 46(7):1249-57. PubMed ID: 16198839
[TBL] [Abstract][Full Text] [Related]
6. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease.
Shuvalova YA; Khasanova ZB; Kaminnaya VI; Samoilova EV; Korotaeva AA; Rubanovich AV; Kaminnyi AI
Gene; 2015 Jun; 564(1):29-34. PubMed ID: 25794429
[TBL] [Abstract][Full Text] [Related]
7. Dipstick proteinuria as a surrogate marker of long-term mortality after acute myocardial infarction.
Ota H; Takeuchi T; Sato N; Hasebe N
J Cardiol; 2013 Nov; 62(5):277-82. PubMed ID: 23806546
[TBL] [Abstract][Full Text] [Related]
8. What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?
Tomaszuk Kazberuk A; Kożuch M; Małyszko J; Bachórzewska Gajewska H; Dobrzycki S; Kosacka U; Musiał WJ
Kardiol Pol; 2012; 70(6):564-72. PubMed ID: 22718372
[TBL] [Abstract][Full Text] [Related]
9. CRP, interleukin-6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up.
Hartford M; Wiklund O; Mattsson Hultén L; Perers E; Person A; Herlitz J; Hurt-Camejo E; Karlsson T; Caidahl K
Int J Cardiol; 2006 Mar; 108(1):55-62. PubMed ID: 16516698
[TBL] [Abstract][Full Text] [Related]
10. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
12. Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction.
Sato A; Aonuma K; Imanaka-Yoshida K; Yoshida T; Isobe M; Kawase D; Kinoshita N; Yazaki Y; Hiroe M
J Am Coll Cardiol; 2006 Jun; 47(11):2319-25. PubMed ID: 16750702
[TBL] [Abstract][Full Text] [Related]
13. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.
Wang KF; Huang PH; Chiang CH; Hsu CY; Leu HB; Chen JW; Lin SJ
Coron Artery Dis; 2013 Jan; 24(1):23-8. PubMed ID: 23151854
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis within one year of first acute myocardial infarction: comparison between non-Q and Q wave myocardial infarction.
Caires G; Pereira D; Freitas AD; Teixeira F; Leite R; Araújo JJ; Cardoso A; Pereira AC; Macedo ME; Diniz M
Rev Port Cardiol; 2000 Dec; 19(12):1223-38. PubMed ID: 11220119
[TBL] [Abstract][Full Text] [Related]
16. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
17. Uric acid in-hospital changes predict mortality in patients with acute myocardial infarction.
Lazaros G; Tsiachris D; Aznaouridis K; Vlachopoulos C; Tsioufis C; Chrysohoou C; Patialiakas A; Masoura C; Stefanadis C
Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1202-9. PubMed ID: 23791297
[TBL] [Abstract][Full Text] [Related]
18. Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome.
Cavusoglu E; Marmur JD; Hojjati MR; Chopra V; Butala M; Subnani R; Huda MS; Yanamadala S; Ruwende C; Eng C; Pinsky DJ
Am J Med; 2011 Aug; 124(8):724-30. PubMed ID: 21787901
[TBL] [Abstract][Full Text] [Related]
19. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
[TBL] [Abstract][Full Text] [Related]
20. Increased mortality associated with low use of clopidogrel in patients with heart failure and acute myocardial infarction not undergoing percutaneous coronary intervention: a nationwide study.
Bonde L; Sorensen R; Fosbøl EL; Abildstrøm SZ; Hansen PR; Kober L; Schramm TK; Bretler DM; Weeke P; Olesen J; Torp-Pedersen C; Gislason GH
J Am Coll Cardiol; 2010 Mar; 55(13):1300-7. PubMed ID: 20338489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
